<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1340</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2018-12-34-39</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>«Venotonics» category: increasing profitability</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Lisovsky</surname><given-names>Pavel</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff id="aff-1">Russian Pharmaceutical Marketing Association</aff><aff id="aff-2">Control Systems Engineering</aff><pub-date date-type="epub" iso-8601-date="2018-12-12" publication-format="electronic"><day>12</day><month>12</month><year>2018</year></pub-date><issue>12</issue><fpage>34</fpage><lpage>39</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2018,</copyright-statement><copyright-year>2018</copyright-year></permissions><abstract>The article presents the major economic indicators of the «oral venotonics» category. It provides the basic methods for defining the product categories, a product category processing technique using the category management tools and describes the methods for determining priority goods in a category. The author highlights the advantages of increasing the share of priorities in the category, and identifies the leaders among venotonics in different price segments, which should be taken into account when building an effective assortment matrix in a pharmacy. The advantages provided by advising the category leaders to pharmacist-in-charge and pharmacists are also identified.</abstract><kwd-group xml:lang="en"><kwd>venotonics</kwd><kwd>economic analysis</kwd><kwd>product categories</kwd><kwd>Detralex</kwd><kwd>category management</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>венотоники</kwd><kwd>экономический анализ</kwd><kwd>товарные категории</kwd><kwd>Детралекс"</kwd><kwd>категорийный менеджмент</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Лисовский П. Аптека в плюсе. Прибыльный аптечный бизнес. М.: Бионика Медиа, 2018.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Инструкция по медицинскому применению препарата Детралекс®: рег. №: П0011469/01 (таблетки, покрытые пленочной оболочкой, 500 мг), рег. №: ЛП-003635 (таблетки, покрытые пленочной оболочкой, 1000 мг), рег. №: ЛП-004247 (суспензия для приема внутрь).</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Результаты исследования Prindex «Мониторинг назначений врачей». Ipsos comcon, 2018.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Saini S.D. et al. Effect of Medication Dosing Frequency on Adherence in Chronic Diseases. Am. J. Manag. Care. 2009 Jun 1; 15(6): 22-33.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Paysant J. et al. Int Angiol. 2008; 27: 81-85.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Garner R.C. et al. Comparison of the absorption of micronized (Oaf/on 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting. Journal of Pharmaceutical Sciences. 2002; 91(1): 32-40.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Сапелкин С.В. и соавт. Хронические заболевания вен: функция клапанов и лейкоцитарно-эндотелиальное взаимодействие, возможности фармакотерапии. Ангиология и сосудистая хирургия. 2017; 23(3): 89.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Инструкция по медицинскому применению препарата Детрагель®: Рег. №: ЛП-001044 (гель для наружного применения).</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>http://www.tovargoda.info/old_winners/2016.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>https://pharmvestnik.ru/content/news/oglash-eny-imena-pobeditelej-13-4-18.html.</mixed-citation></ref></ref-list></back></article>
